查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1586430

GLP-1類比市場，規模，佔有率，趨勢，產業分析報告:各給藥途徑，各產品，各用途，各流通管道，各地區 - 市場預測，2025年～2034年

GLP-1 Analogues Market Size, Share, Trends, Industry Analysis Report: By Route of Administration, Product, Application, Distribution Channel, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據Polaris Market Research的最新研究，全球GLP-1類似物市場預計到2034年將達到3,228.5億美元。該研究報告對當前市場動態提供了詳細的見解，並對未來市場成長進行了分析。

由於 2 型糖尿病和肥胖症的盛行率不斷上升、醫療保健基礎設施的快速發展以及對這些慢性疾病的認識不斷提高，GLP-1 類似物市場正在經歷顯著增長。胰高血糖素樣勝肽-1 (GLP-1) 類似物是一種模仿天然荷爾蒙 GLP-1 作用的藥物，在調節血糖水平和食慾方面發揮重要作用。這些類似的藥物對於治療第 2 型糖尿病至關重要。最近，它也被批准用於治療肥胖症，進一步擴大了市場成長。

GLP-1 類似物市場的成長是由第 2 型糖尿病盛行率的上升所推動的。盛行率的上升很大程度上是由於生活方式的改變，包括富含加工食品、糖和脂肪的不健康飲食以及久坐的行為。城市化導致越來越多的人採用西方化的飲食和生活方式，而這是已知的導致糖尿病的風險因素。此外，人口老化也是第2型糖尿病發生率上升的因素。這些因素導致對有效糖尿病藥物的需求激增，其中 GLP-1 類似物因其在降低血糖水平和降低心血管事件風險方面被證明的有效性而處於領先地位。

肥胖人數的增加也是 GLP-1 類似物市場成長的主要驅動力。肥胖的盛行率在世界各地不斷增加，特別是在亞太地區等經濟成長和都市化快速發展的地區。這些地區中產階級人口的不斷增長，導致高熱量、低營養食品的消費量增加，而體力活動減少，這兩者都導致肥胖率上升。 GLP-1類似物核准用於體重管理，為市場成長提供了新的機會。此外，醫療保健基礎設施的進步（尤其是在新興國家）使得這些治療更容易獲得。政府和私人醫療保健提供者正在投資提高診斷能力和擴大醫療保健服務，以便更早發現和更有效地管理糖尿病和肥胖症。此外，遠距醫療和網路藥局的日益普及，改善了 GLP-1 類似物的獲取，特別是在偏遠和服務不足的地區，進一步推動了市場成長。

GLP-1 類似物市場報告重點

按產品類型劃分，Ozempic 對管理 2 型糖尿病患者的血糖水平非常有效，在 2024 年佔據 GLP-1 類似物市場最大的銷售佔有率。

由於網路普及率的提高和競爭性定價策略，按銷售管道劃分的線上藥局部門預計在預測期內將實現顯著的複合年增長率。

由於第 2 型糖尿病和肥胖症的盛行率很高，到 2024 年，北美將佔據最大的市場佔有率。

由於醫療保健機會的增加和中產階級人口的增加，預計亞太市場將在預測期內實現最高的複合年增長率。

主要的全球市場參與者是AstraZeneca; Bristol-Myers Squibb Company; D&D Pharmatech; Eccogen; Eli Lilly and Company; Glenmark Pharmaceuticals Ltd.; Hanmi Pharm. Co., Ltd.; Lexicon Pharmaceuticals, Inc.; Merck & Co., Inc.; Novo Nordisk A/S; and Sanofi.。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球GLP-1類比市場洞察

  • 應用概述
  • GLP-1類比市場動態
    • 促進因素和機會
      • 老齡人口增加推動市場成長
      • 2 型糖尿病盛行率的不斷上升推動了市場的成長
    • 阻礙因素和課題巷
      • 與替代藥物的競爭阻礙了 GLP-1 類似物市場的成長
  • PESTEL分析
  • GLP-1類比市場應用趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球GLP-1類比市場:各給藥途徑

  • 主要調查結果
  • 簡介
  • 非口服給藥
  • 口服給藥

第6章 全球GLP-1類比市場:各產品

  • 主要調查結果
  • 簡介
  • Ozempic
  • Trulicity
  • Mounjaro
  • Wegovy
  • Rybelsus
  • Saxenda
  • Victoza
  • Zepbound
  • 其他的產品

第7章 全球GLP-1類比市場:各用途

  • 主要調查結果
  • 簡介
  • 第二型糖尿病
  • 肥胖

第8章 全球GLP-1類比市場:各流通管道

  • 主要調查結果
  • 簡介
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第9章 全球GLP-1類比市場:各地區

  • 主要調查結果
  • 簡介
    • GLP-1類比市場評估:各地區，2020-2034年
  • 北美
    • 北美:各給藥途徑，2020～2034年
    • 北美:各產品，2020-2034年
    • 北美:各用途，2020-2034年
    • 北美:各流通管道，2020年～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各給藥途徑，2020-2034年
    • 歐洲:各產品，2020-2034年
    • 歐洲:各用途，2020-2034年
    • 歐洲:各流通管道，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各給藥途徑，2020～2034年
    • 亞太地區:各產品，2020～2034年
    • 亞太地區:各用途，2020-2034年
    • 亞太地區:各流通管道，2020年～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各給藥途徑，2020～2034年
    • 中東·非洲:各產品，2020～2034年
    • 中東·非洲:各用途，2020～2034年
    • 中東·非洲:各流通管道，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲
  • 南美
    • 南美:各給藥途徑，2020-2034年
    • 南美:各產品，2020-2034年
    • 南美:各用途，2020-2034年
    • 南美:各流通管道，2020-2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第10章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第11章 企業簡介

  • AstraZeneca.
  • Bristol-Myers Squibb Company
  • D&D Pharmatech
  • Eccogen
  • Eli Lilly and Company
  • Glenmark Pharmaceuticals Ltd.
  • Hanmi Pharm. Co., Ltd.
  • Lexicon Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • Sanofi
  • Rollins, Inc
  • Sumitomo Chemical Company, Limited
  • Syngenta
  • Terminix
Product Code: PM5147

The global GLP-1 analogues market size is expected to reach USD 322.85 billion by 2034, according to a new study by Polaris Market Research. The report "GLP-1 Analogues Market Share, Size, Trends, Industry Analysis Report - By Route of Administration (Subcutaneous Route and Oral Route), Product, Application, Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Segment Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The GLP-1 analogues market has been witnessing significant growth, driven by the increasing prevalence of type 2 diabetes and obesity, surging advancements in healthcare infrastructure, and rising awareness of these chronic conditions. Glucagon-like peptide-1 (GLP-1) analogues are a class of medications that mimic the action of the naturally occurring hormone GLP-1, which plays a crucial role in regulating blood sugar levels and appetite. These analogues have become essential in managing type 2 diabetes. Recently, they have gained approval for obesity treatment, further expanding their market growth.

The primary growth driver for the GLP-1 analogues market is the escalating prevalence of type 2 diabetes. This increase in disease prevalence is largely attributed to lifestyle changes, such as unhealthy diets rich in processed foods, sugar, and fats, combined with sedentary behaviors. The rise in urbanization has led to more people adopting a Westernized diet and lifestyle, which are known risk factors for developing diabetes. Additionally, the aging population is contributing to the higher incidence of type 2 diabetes, as the risk of developing the condition increases with age. These factors have led to a surge in demand for effective diabetes treatments, with GLP-1 analogues being at the forefront due to their proven efficacy in lowering blood glucose levels and reducing the risk of cardiovascular events.

The rising prevalence of obesity is another significant driver of the GLP-1 analogues market growth. Obesity prevalence is increasing globally, particularly in regions undergoing rapid economic growth and urbanization, such as Asia Pacific. The growing middle-class population in these regions is leading to increased consumption of calorie-dense, low-nutrient foods and reduced physical activity, both of which contribute to rising obesity rates. The approval of GLP-1 analogues for weight management has opened up new opportunities for market growth. Furthermore, advancements in healthcare infrastructure, particularly in emerging economies, are making these treatments more accessible. Governments and private healthcare providers are investing in improving diagnostic capabilities and expanding healthcare services, enabling earlier detection and more effective management of diabetes and obesity. Additionally, the growing adoption of telemedicine and online pharmacies is enhancing access to GLP-1 analogues, especially in remote and underserved areas, further driving the market growth.

GLP-1 Analogues Market Report Highlights

By product, in 2024, the ozempic segment accounted for the largest revenue share in the GLP-1 analogues market due to its strong efficacy in managing blood glucose levels in individuals affected by type 2 diabetes.

The online pharmacies segment, based on distribution channel, is expected to record a significant CAGR during the forecast period due to expanding internet penetration and competitive pricing strategies.

In 2024, North America accounted for the largest market share due to the high prevalence of type 2 diabetes and obesity.

The Asia Pacific market is expected to record the highest CAGR during the forecast period due to the expanding healthcare access and growing middle-class population.

A few global key market players are AstraZeneca; Bristol-Myers Squibb Company; D&D Pharmatech; Eccogen; Eli Lilly and Company; Glenmark Pharmaceuticals Ltd.; Hanmi Pharm. Co., Ltd.; Lexicon Pharmaceuticals, Inc.; Merck & Co., Inc.; Novo Nordisk A/S; and Sanofi.

Polaris Market Research has segmented the GLP-1 analogues market report on the basis of route of administration, product, application, distribution channel, and region:

By Route of Administration Outlook (Revenue - USD Billion, 2020-2034)

  • Subcutaneous Route
  • Oral Route

By Product Outlook (Revenue - USD Billion, 2020-2034)

  • Ozempic
  • Trulicity
  • Mounjaro
  • Wegovy
  • Rybelsus
  • Saxenda
  • Victoza
  • Zepbound
  • Other Products

By Application Outlook (Revenue - USD Billion, 2020-2034)

  • Type 2 Diabetes Mellitus
  • Obesity
  • Others Applications

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global GLP-1 Analogues Market Insights

  • 4.1. GLP-1 Analogues Market - Application Snapshot
  • 4.2. GLP-1 Analogues Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. The Rise of the Aging Population is Driving Market Growth
      • 4.2.1.2. The Increasing Prevalence of Type 2 Diabetes Are Driving the Market Growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Competition from Alternative Drugs are hindering the GLP-1 Analogues market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. GLP-1 Analogues Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global GLP-1 Analogues Market, by Route of Administration

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • 5.3. Parenteral Route
    • 5.3.1. Global GLP-1 Analogues Market, by Parenteral Route, by Region, 2020-2034 (USD Billion)
  • 5.4. Oral Route
    • 5.4.1. Global GLP-1 Analogues Market, by Oral Route, by Region, 2020-2034 (USD Billion)

6. Global GLP-1 Analogues Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • 6.3. Ozempic
    • 6.3.1. Global GLP-1 Analogues Market, by Ozempic, by Region, 2020-2034 (USD Billion)
  • 6.4. Trulicity
    • 6.4.1. Global GLP-1 Analogues Market, by Trulicity, by Region, 2020-2034 (USD Billion)
  • 6.5. Mounjaro
    • 6.5.1. Global GLP-1 Analogues Market, by Mounjaro, by Region, 2020-2034 (USD Billion)
  • 6.6. Wegovy
    • 6.6.1. Global GLP-1 Analogues Market, by Wegovy, by Region, 2020-2034 (USD Billion)
  • 6.7. Rybelsus
    • 6.7.1. Global GLP-1 Analogues Market, by Rybelsus, by Region, 2020-2034 (USD Billion)
  • 6.8. Saxenda
    • 6.8.1. Global GLP-1 Analogues Market, by Saxenda, by Region, 2020-2034 (USD Billion)
  • 6.9. Victoza
    • 6.9.1. Global GLP-1 Analogues Market, by Victoza, by Region, 2020-2034 (USD Billion)
  • 6.10. Zepbound
    • 6.10.1. Global GLP-1 Analogues Market, by Zepbound, by Region, 2020-2034 (USD Billion)
  • 6.11. Other Products
    • 6.11.1. Global GLP-1 Analogues Market, by Other Products, by Region, 2020-2034 (USD Billion)

7. Global GLP-1 Analogues Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • 7.3. Type 2 Diabetes Mellitus
    • 7.3.1. Global GLP-1 Analogues Market, by Type 2 Diabetes Mellitus, by Region, 2020-2034 (USD Billion)
  • 7.4. Obesity
    • 7.4.1. Global GLP-1 Analogues Market, by Obesity, by Region, 2020-2034 (USD Billion)

8. Global GLP-1 Analogues Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.3. Hospital Pharmacies
    • 8.3.1. Global GLP-1 Analogues Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
  • 8.4. Retail Pharmacies
    • 8.4.1. Global GLP-1 Analogues Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
  • 8.5. Online Pharmacies
    • 8.5.1. Global GLP-1 Analogues Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)

9. Global GLP-1 Analogues Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. GLP-1 Analogues Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. GLP-1 Analogues Market - North America
    • 9.3.1. North America: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.3.2. North America: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
    • 9.3.3. North America: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
    • 9.3.4. North America: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.3.5. GLP-1 Analogues Market - U.S.
      • 9.3.5.1. U.S.: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.3.5.2. U.S.: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.3.5.3. U.S.: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.3.5.4. U.S.: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.3.6. GLP-1 Analogues Market - Canada
      • 9.3.6.1. Canada: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.4. GLP-1 Analogues Market - Europe
    • 9.4.1. Europe: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.2. Europe: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
    • 9.4.3. Europe: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
    • 9.4.4. Europe: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.5. GLP-1 Analogues Market - UK
      • 9.4.5.1. UK: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.6. GLP-1 Analogues Market - France
      • 9.4.6.1. France: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.6.2. France: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.4.6.3. France: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.4.6.4. France: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.7. GLP-1 Analogues Market - Germany
      • 9.4.7.1. Germany: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.8. GLP-1 Analogues Market - Italy
      • 9.4.8.1. Italy: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.9. GLP-1 Analogues Market - Spain
      • 9.4.9.1. Spain: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.10. GLP-1 Analogues Market - Netherlands
      • 9.4.10.1. Netherlands: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.11. GLP-1 Analogues Market - Russia
      • 9.4.11.1. Russia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.4.12. GLP-1 Analogues Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.5. GLP-1 Analogues Market - Asia Pacific
    • 9.5.1. Asia Pacific: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.5. GLP-1 Analogues Market - China
      • 9.5.5.1. China: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.5.2. China: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.5.5.3. China: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.5.5.4. China: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.6. GLP-1 Analogues Market - India
      • 9.5.6.1. India: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.6.2. India: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.5.6.3. India: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.5.6.4. India: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.7. GLP-1 Analogues Market - Malaysia
      • 9.5.7.1. Malaysia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.8. GLP-1 Analogues Market - Japan
      • 9.5.8.1. Japan: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.9. GLP-1 Analogues Market - Indonesia
      • 9.5.9.1. Indonesia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.10. GLP-1 Analogues Market - South Korea
      • 9.5.10.1. South Korea: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.11. GLP-1 Analogues Market - Australia
      • 9.5.11.1. Australia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.5.12. GLP-1 Analogues Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.6. GLP-1 Analogues Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.5. GLP-1 Analogues Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.6. GLP-1 Analogues Market - UAE
      • 9.6.6.1. UAE: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.7. GLP-1 Analogues Market - Israel
      • 9.6.7.1. Israel: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.8. GLP-1 Analogues Market - South Africa
      • 9.6.8.1. South Africa: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.6.9. GLP-1 Analogues Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 9.7. GLP-1 Analogues Market - Latin America
    • 9.7.1. Latin America: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.7.5. GLP-1 Analogues Market - Mexico
      • 9.7.5.1. Mexico: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.7.6. GLP-1 Analogues Market - Brazil
      • 9.7.6.1. Brazil: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.7.7. GLP-1 Analogues Market - Argentina
      • 9.7.7.1. Argentina: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 9.7.8. GLP-1 Analogues Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. AstraZeneca.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Bristol-Myers Squibb Company
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. D&D Pharmatech
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Eccogen
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Eli Lilly and Company
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Glenmark Pharmaceuticals Ltd.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Hanmi Pharm. Co., Ltd.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Lexicon Pharmaceuticals, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Merck & Co., Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Novo Nordisk A/S
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Sanofi
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Rollins, Inc
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Sumitomo Chemical Company, Limited
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Syngenta
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Terminix
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development

List of Tables:

  • Table 1 Global GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 2 Global GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 3 Global GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 4 Global GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 5 North America: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 6 North America: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 7 North America: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 8 North America: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 9 U.S.: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 10 U.S.: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 11 U.S.: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 12 U.S.: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 13 Canada: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 14 Canada: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 15 Canada: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 16 Canada: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 17 Europe: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 18 Europe: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 19 Europe: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 20 Europe: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 21 UK: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 22 UK: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 23 UK: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 24 UK: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 25 France: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 26 France: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 27 France: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 28 France: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 29 Germany: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 30 Germany: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 31 Germany: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 32 Germany: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 33 Italy: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 34 Italy: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 35 Italy: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Italy: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 37 Spain: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 38 Spain: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 39 Spain: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 40 Spain: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 41 Netherlands: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 42 Netherlands: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 43 Netherlands: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 44 Netherlands: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 45 Russia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 46 Russia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 47 Russia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 48 Russia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 57 China: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 58 China: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 59 China: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 60 China: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 61 India: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 62 India: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 63 India: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 64 India: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 65 Malaysia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 66 Malaysia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 67 Malaysia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 68 Malaysia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 69 Japan: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 70 Japan: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 71 Japan: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 72 Japan: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 73 Indonesia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 74 Indonesia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 75 Indonesia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 76 Indonesia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 77 South Korea: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 78 South Korea: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 79 South Korea: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 80 South Korea: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 81 Australia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 82 Australia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 83 Australia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 84 Australia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 97 UAE: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 98 UAE: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 99 UAE: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 100 UAE: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 101 Israel: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 102 Israel: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 103 Israel: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 104 Israel: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 105 South Africa: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 106 South Africa: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 107 South Africa: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 108 South Africa: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 113 Latin America: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 114 Latin America: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 115 Latin America: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 116 Latin America: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 117 Mexico: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 118 Mexico: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 119 Mexico: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 120 Mexico: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 121 Brazil: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 122 Brazil: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 123 Brazil: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 124 Brazil: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 125 Argentina: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 126 Argentina: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 127 Argentina: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 128 Argentina: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: GLP-1 Analogues Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: GLP-1 Analogues Market, by Product, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: GLP-1 Analogues Market, by Application, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: GLP-1 Analogues Market, by Distribution Channel, 2020-2034 (USD Billion)
  • List of Figures:
  • Figure 1. Global GLP-1 Analogues Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Route of Administration
  • Figure 7. Global GLP-1 Analogues Market, by Route of Administration, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Product
  • Figure 9. Global GLP-1 Analogues Market, by Product, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global GLP-1 Analogues Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Distribution Channel
  • Figure 13. Global GLP-1 Analogues Market, by Distribution Channel, 2024 & 2034 (USD Billion)